This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

The Supreme Court has ruled 5-4 to allow the Trump administration’s NIH funding cuts to continue, impacting more than 1,700 medical research grants in areas including heart disease, HIV/AIDS, ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

Michael Weis, SM, is principal of Michael B. Weis Consultancy, P.O. Box 414, Ringoes, NJ 08551, (609) 466-1261, fax (609) 466-9353, email: [email protected].

A new exploratory study will evaluate the safety of Anktiva in patients with long COVID, with secondary and exploratory ...

The Phase II EvolvE trial (NCT05774184) confirmed barzolvolimab’s mechanism of action but showed no measurable improvement in dysphagia symptoms or esophageal inflammation in patients with ...

The Denali trial confirmed non-inferiority of NCX 470 to latanoprost in lowering intraocular pressure, with consistent efficacy, favorable safety, and supportive results from the earlier Mont Blanc ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient ...

In this episode of the Applied Clinical Trials Brief, we spotlight a recent video interview in which Jon Walsh, founder and ...